Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2026-03-29 @ 4:24 AM
Study NCT ID:
NCT01725204
Status:
COMPLETED
Last Update Posted:
2017-09-25
First Post:
2012-11-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Pegylated IFN-alpha 2B Added to Dasatinib in Newly Diagnosed Chronic Phase Myeloid Leukemia
Sponsor:
Norwegian University of Science and Technology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-09
Start Date Type:
ACTUAL
Primary Completion Date:
2016-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-05
Completion Date Type:
ACTUAL
First Submit Date:
2012-11-08
First Submit QC Date:
None
Study First Post Date:
2012-11-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-09-21
Last Update Post Date:
2017-09-25
Last Update Post Date Type:
ACTUAL